How Vitamin A might have helped an Autistic boy read clearly
Dr Megson, says that Autism may be a disorder linked to the disruption of the G-alpha protein, affecting retinoid receptors in the brain.
A study of 60 autistic children suggests that autism may be caused by inserting a G-alpha protein defect, the pertussis toxin found in the DPT vaccine, into genetically at-risk children.
Dr Megson studied the 60 children at the Medical College of Virginia. Please, encourage more of this research by showering this scientist with encouragement, invite for a public lecture and perhaps dollar bills in the mail……….
For these and other reasons I started the boy on cod liver oil (3500 IU of Vitamin A) and a gluten free diet. After one week, he began to sit farther from the television and to notice paintings on the walls at home. He had always gone out of his way to follow the sidewalk and driveway to meet the school bus. On Vitamin A, he began to run across the grass directly from the front door to the school bus. After three weeks, he was given a single dose of Urocholine, an alpha muscarinic receptor agonist, to increase bile and pancreatic secretions and indirectly stimulate hippocampal retinoid receptors. It has minimal cardiac effect, is FDA approved, has been used safely in children since the 1970’s for reflux, and does not cross the blood–brain barrier, unlike secretin (17). It stimulates post-synaptic cell membranes via receptors for acetyl- choline, a neurotransmitter in the parasympathetic system.
Thirty minutes after administration of the Urocholine, the patient, who was sitting in a chair, swung his feet over the side, pointed to a glass candy jar on my shelf and said, ‘May I have the red Jolly Rancher® please?’ He had read the label on the candy in the clear jar. These were the first words he had spoken in eight years, and the first proof that he could read. We took him outside and he said, ‘The leaves, the leaves on the trees are green! I see! I see!’ When I asked to take his picture he looked at the camera, smiled and waved. When he left the office I said, ‘See you later.’ He asked, ‘What time?’
In this child’s case, after several weeks of treatment with Vitamin A in CLO 3500 IU/day, the Urocholine acted like a switch. When absorbed, he immediately became socially engaged, made excellent eye contact, hugged his mother tightly and said, ‘I love you so much,’ looking at her face. At that point we both realized that this child had a blocked pathway. The change in language and social interaction was dramatic and imme- diate. Yet he reverted to the pre-treatment state of silence when the dose wore off. ………
Correspondence to: M. N. Megson, Developmental Pediatrician, Assistant Professor of Pediatrics, Medical College of Virginia Hospitals/Virginia Commonwealth University, Pediatric and Adolescent Ability Center, 7229 Forest Avenue, Suite 211, Richmond, VA 23226, USA. Phone: +1 804 673 9028; Fax: +1 804 673 9195
Pursue natural 